June 2, 2020
Securities and Exchange Commission
100 F Street, N.E.
Form RW filled May 29, 2020 (the “RW”) with respect to Amendment Number 1 to Registration Statement on Form S-1 filed January 8, 2019 Registration No. 333- 229146 and ordered Effective February 11, 2019.
Ladies and Gentlemen:
The undersigned issuer hereby requests that the above captioned RW be withdrawn. The issuer is filing a Post-Effective Amendment in its stead.
Very truly yours,
Endonovo Therapeutics, Inc.
By: | /s/ Alan Collier, CEO | |
Alan Collier, CEO |